Product Description: Scalaradial is an inhibitor for bee venom phospholipase A2 (PLA2) and transient receptor potential melastatin 2 (TRPM2) ion channels, with IC50 of 0.07 and 0.21 μM. Scalaradial regulates the phosphorylation of ERK, by inhibiting secretory PLA2 and Akt. Scalaradial inhibits the PMA (HY-18739)-induced release of Arachidonic acid (HY-109590) in the mouse peritoneal macrophage[1][2][3].
Applications: COVID-19-immunoregulation
Formula: C27H40O4
References: [1]Starkus JG, et al., Scalaradial Is a Potent Inhibitor of Transient Receptor Potential Melastatin 2 (TRPM2) Ion Channels. J Nat Prod. 2017 Oct 27;80(10):2741-2750./[2]de Carvalho MS, et al., Two-step inactivation of bee venom phospholipase A2 by scalaradial. Biochem Pharmacol. 1991 Sep 27;42(8):1621-6. /[3]Xie Y, et al., Biphasic regulation of extracellular signal-regulated kinases by scalaradial, a secretory phospholipase A(2) inhibitor. Cancer Biol Ther. 2006 Aug;5(8):988-92.
CAS Number: 53527-28-9
Molecular Weight: 428.60
Research Area: Cancer; Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Akt;ERK;Phospholipase;TRP Channel